16:51 EST Altimmune (ALT) files $400M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT:
- Altimmune’s Innovative Approach to MASH and Obesity: A Promising Future with Pemvidutide
- Altimmune Reports 2024 Financial Results and R&D Progress
- Altimmune reports Q4 EPS (33c), consensus (34c)
- Altimmune Expands Board Amid Late-Stage Drug Development
- Altimmune appoints Teri Lawver, Jerry Durso to board